Dasotraline Adult ADHD Study

Clinical trial NCT02276209 · COMPLETED

Trial details

NCT number: NCT02276209
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Attention Deficit Hyperactivity Disorder

Start date: 2014-12-01
Primary completion: 2016-09-01
Enrollment: 636

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.